Clinicians who are attempting to quantify the risk of osteoporosis or osteoporotic fracture should also consider additional evaluation or referral if there is a history or clinical suspicion of rarer high risk conditions, such as endocrine or metabolic causes of secondary osteoporosis eg, hypercortisolism, hyperparathyroidism, or acromegaly, disorders of collagen metabolism, and high risk medications or multiple moderate risk medications as described in the text <a href=https://priligy.me/>buy priligy pills</a> Though not used to treat rheumatologic disorders, rapamycin inhibitor of mammalian target of rapamycin, or mTOR is worth noting in this review
